Product Highlight-Vaxneuvance

13 Mar 2025
Product Highlight-Vaxneuvance
1. Elicits a higher immune response for serotype 3

2. Adds key disease-causing serotypes 22F and 33F

3. Shows non-inferior immune responses compared to PCV13 (13 shared serotypes)

Reference:
1. Vaxneuvance™ Product Insert Malaysia. Available at: Product Search, National Pharmaceutical Regulatory Agency https://quest3plus.bpfk.gov.my/pmo2/index.php

Further information is available in MIMS section 12b.

For healthcare professionals only.

MERCK SHARP & DOHME (MALAYSIA) SDN BHD
Company No: 60181-P
B-22-1 & B-22-2, The Ascent Paradigm, No. 1, Jalan SS 7/26A, Kelana Jaya, 47301 Petaling Jaya, Selangor
Tel: (+60-3) 7499 1600 • Fax: (+60-3) 7499 1700
Website: www.msd-malaysia.com

Related MIMS Drugs